| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.71e-08 | 11 | 167 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.10e-08 | 37 | 167 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.56e-08 | 38 | 167 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 7.26e-08 | 14 | 167 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.04e-07 | 21 | 167 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.35e-05 | 37 | 167 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.55e-05 | 38 | 167 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.00e-05 | 46 | 167 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 5.25e-05 | 79 | 167 | 6 | GO:0004521 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.79e-04 | 38 | 167 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.76e-04 | 118 | 167 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 7.87e-04 | 22 | 167 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.00e-03 | 136 | 167 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.00e-03 | 136 | 167 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 NUP85 NUMA1 MACROH2A1 ERVK-7 ERVK-10 MRPS30 DST HMCN1 PRELP ERVK-8 ERVK-18 PODN MACF1 ERVK-19 ERVK-25 EPB42 | 1.32e-03 | 891 | 167 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | dynein complex binding | 1.61e-03 | 28 | 167 | 3 | GO:0070840 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.66e-03 | 262 | 167 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.78e-03 | 152 | 167 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | TTF2 MYO1D ABCA13 MYO19 DHX38 DNAH2 TOR1A BTAF1 DHX15 MACF1 MYH15 SLFN11 MYO15A | 2.01e-03 | 614 | 167 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO1D MYO19 LRRK2 NUMA1 TOGARAM2 APC TOR1A RUSC1 PARVG SHROOM4 DST SNX6 NISCH MYLIP MACF1 MYH15 DNAI7 MYO15A MYO16 | 2.15e-03 | 1099 | 167 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.17e-03 | 31 | 167 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | actin binding | MYO1D MYO19 LRRK2 RUSC1 PARVG SHROOM4 DST MACF1 MYH15 MYO15A MYO16 | 2.38e-03 | 479 | 167 | 11 | GO:0003779 |
| GeneOntologyBiologicalProcess | DNA integration | 3.54e-08 | 13 | 163 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | cell cycle process | CUL4B CUL4A PLK2 HUS1 MYO19 NUMA1 APC EXOC3 MACROH2A1 MAU2 MEI1 CNTROB USP19 EXOC8 CENPP CDK5RAP3 LATS2 RRS1 CDC16 CEP250 GPSM2 TTI1 SLFN11 ATM STAG3 MYO16 TBX1 PCID2 PCNT | 2.81e-06 | 1441 | 163 | 29 | GO:0022402 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.77e-05 | 48 | 163 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | CUL4A PLK2 HUS1 APC MACROH2A1 CDK5RAP3 TTI1 SLFN11 ATM MYO16 PCID2 | 3.85e-05 | 311 | 163 | 11 | GO:1901988 |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | CUL4B CUL4A PLK2 HUS1 MYO19 NUMA1 APC MACROH2A1 USP19 CDK5RAP3 CDC16 CEP250 GPSM2 TTI1 SLFN11 ATM MYO16 TBX1 PCID2 | 4.07e-05 | 845 | 163 | 19 | GO:0010564 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | CUL4B CUL4A PLK2 HUS1 NUMA1 APC EXOC3 CNTROB EXOC8 CDK5RAP3 LATS2 RRS1 CDC16 GPSM2 SLFN11 ATM MYO16 PCID2 PCNT | 4.69e-05 | 854 | 163 | 19 | GO:1903047 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 5.07e-05 | 83 | 163 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | CUL4B CUL4A PLK2 HUS1 APC MACROH2A1 CDK5RAP3 CDC16 TTI1 SLFN11 ATM MYO16 TBX1 PCID2 | 6.33e-05 | 516 | 163 | 14 | GO:1901987 |
| GeneOntologyBiologicalProcess | cilium organization | IFT172 DNAH2 RFX2 CNTROB ASAP1 WDR19 PTPDC1 CFAP54 DNAAF10 NISCH CEP250 TTC17 PCNT | 1.09e-04 | 476 | 163 | 13 | GO:0044782 |
| GeneOntologyBiologicalProcess | cell projection assembly | NUP85 FGD2 IFT172 DNAH2 APC PARVG RFX2 CNTROB ASAP1 WDR19 PTPDC1 CFAP54 DNAAF10 NISCH CEP250 PCNT | 1.10e-04 | 685 | 163 | 16 | GO:0030031 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | MYO19 LRRK2 NUMA1 APC TOR1A EXOC3 MEI1 EXOC8 CDR2L C17orf75 SNX6 RRS1 GPSM2 ATM | 1.15e-04 | 546 | 163 | 14 | GO:0051656 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle endocytosis | 1.31e-04 | 13 | 163 | 3 | GO:1900244 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | CUL4B CUL4A PLK2 HUS1 APC MACROH2A1 CDK5RAP3 LATS2 CDC16 TTI1 SLFN11 ATM MYO16 TBX1 PCID2 | 1.40e-04 | 627 | 163 | 15 | GO:0044770 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | CUL4A PLK2 HUS1 APC MACROH2A1 CDK5RAP3 TTI1 SLFN11 ATM MYO16 PCID2 | 1.49e-04 | 362 | 163 | 11 | GO:0010948 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | CUL4B CUL4A PLK2 HUS1 NUMA1 APC EXOC3 CNTROB EXOC8 CDK5RAP3 LATS2 RRS1 CDC16 CEP250 GPSM2 SLFN11 ATM MYO16 PCID2 PCNT | 1.52e-04 | 1014 | 163 | 20 | GO:0000278 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 2.13e-04 | 257 | 163 | 9 | GO:0007163 | |
| GeneOntologyBiologicalProcess | cilium assembly | IFT172 DNAH2 RFX2 CNTROB ASAP1 WDR19 PTPDC1 CFAP54 DNAAF10 NISCH CEP250 PCNT | 2.21e-04 | 444 | 163 | 12 | GO:0060271 |
| GeneOntologyBiologicalProcess | microtubule-based process | PLK2 IFT172 NUMA1 DNAH2 TOGARAM2 APC MEI1 CNTROB WDR19 CDR2L CFAP54 DST DNAAF10 NISCH CEP250 GPSM2 MACF1 DNAI7 PCNT WDR72 | 2.66e-04 | 1058 | 163 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | NUP85 FGD2 IFT172 DNAH2 APC RFX2 CNTROB ASAP1 WDR19 PTPDC1 CFAP54 DNAAF10 NISCH CEP250 PCNT | 2.86e-04 | 670 | 163 | 15 | GO:0120031 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle recycling | 3.04e-04 | 17 | 163 | 3 | GO:1903423 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | CUL4A PLK2 HUS1 APC MACROH2A1 CDK5RAP3 LATS2 TTI1 SLFN11 ATM MYO16 PCID2 | 3.30e-04 | 464 | 163 | 12 | GO:0045786 |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 3.40e-04 | 217 | 163 | 8 | GO:0000075 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle phase transition | 3.61e-04 | 219 | 163 | 8 | GO:1901991 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | CUL4B CUL4A PLK2 HUS1 APC CDK5RAP3 CDC16 SLFN11 ATM MYO16 PCID2 | 3.66e-04 | 402 | 163 | 11 | GO:1901990 |
| GeneOntologyBiologicalProcess | regulation of chromosome separation | 4.08e-04 | 79 | 163 | 5 | GO:1905818 | |
| GeneOntologyCellularComponent | cell cortex | MYO1D NUMA1 APC EXOC3 FRYL EXOC8 SHROOM4 DST HMCN1 GPSM2 MACF1 EPB42 | 3.59e-05 | 371 | 163 | 12 | GO:0005938 |
| GeneOntologyCellularComponent | lateral cell cortex | 6.04e-05 | 2 | 163 | 2 | GO:0097575 | |
| GeneOntologyCellularComponent | myosin complex | 9.66e-05 | 59 | 163 | 5 | GO:0016459 | |
| MousePheno | abnormal intracellular organelle morphology | CUL4A NEPRO HUS1 MRS2 LRRK2 APC TOR1A ANO5 RFX2 FAH DST LATS2 CEP250 HINT2 GPSM2 ATM ULK1 | 9.84e-06 | 546 | 128 | 17 | MP:0014239 |
| Domain | ARM-type_fold | CAB39 DOCK8 IFT172 LRRK2 USP24 TOGARAM2 APC FRYL BTAF1 MEI1 TEX10 RYR3 THADA UPF2 NBEAL2 TTI1 ATM STAG3 | 4.11e-10 | 339 | 154 | 18 | IPR016024 |
| Domain | ARM-like | CAB39 DOCK8 LRRK2 TOGARAM2 APC FRYL BTAF1 MEI1 TEX10 NBEAL2 TTI1 STAG3 | 2.53e-06 | 270 | 154 | 12 | IPR011989 |
| Domain | LRR | LRRK2 LRRIQ4 TLR9 LRRC3B PRELP NISCH TLR3 SLITRK5 PODN LRRD1 | 6.67e-06 | 201 | 154 | 10 | PS51450 |
| Domain | LRR_8 | 1.24e-05 | 171 | 154 | 9 | PF13855 | |
| Domain | LRR_1 | LRRK2 LRRIQ4 TLR9 LRRC3B PRELP NISCH TLR3 SLITRK5 PODN LRRD1 | 1.41e-05 | 219 | 154 | 10 | PF00560 |
| Domain | Myosin_head_motor_dom | 1.44e-05 | 38 | 154 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.44e-05 | 38 | 154 | 5 | PS51456 | |
| Domain | Myosin_head | 1.44e-05 | 38 | 154 | 5 | PF00063 | |
| Domain | MYSc | 1.44e-05 | 38 | 154 | 5 | SM00242 | |
| Domain | - | NLRP7 LRRK2 LRRIQ4 TLR9 NLRC4 LRRC3B PRELP NISCH TLR3 SLITRK5 PODN LRRD1 | 1.47e-05 | 321 | 154 | 12 | 3.80.10.10 |
| Domain | LRR_TYP | 1.64e-05 | 177 | 154 | 9 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.64e-05 | 177 | 154 | 9 | IPR003591 | |
| Domain | L_dom-like | NLRP7 LRRK2 LRRIQ4 TLR9 NLRC4 LRRC3B PRELP NISCH TLR3 SLITRK5 PODN LRRD1 | 1.82e-05 | 328 | 154 | 12 | IPR032675 |
| Domain | Leu-rich_rpt | LRRK2 LRRIQ4 TLR9 LRRC3B PRELP NISCH TLR3 SLITRK5 PODN LRRD1 | 8.60e-05 | 271 | 154 | 10 | IPR001611 |
| Domain | - | 9.60e-05 | 222 | 154 | 9 | 1.25.10.10 | |
| Domain | Cullin_repeat-like_dom | 1.15e-04 | 12 | 154 | 3 | IPR016159 | |
| Domain | IQ | 1.20e-04 | 93 | 154 | 6 | PS50096 | |
| Domain | Ankyrin_rpt-contain_dom | LRRK2 ASAP1 NRARP ANKRD36B RFXANK ASB3 ANKRD24 ANKRD36 MYO16 | 2.64e-04 | 254 | 154 | 9 | IPR020683 |
| Domain | Ankyrin_rpt | LRRK2 ASAP1 NRARP ANKRD36B RFXANK ASB3 ANKRD24 ANKRD36 MYO16 | 3.31e-04 | 262 | 154 | 9 | IPR002110 |
| Domain | TPR_REGION | 4.43e-04 | 165 | 154 | 7 | PS50293 | |
| Domain | TPR | 4.43e-04 | 165 | 154 | 7 | PS50005 | |
| Domain | IQ | 5.53e-04 | 81 | 154 | 5 | SM00015 | |
| Domain | Ank | 6.18e-04 | 228 | 154 | 8 | PF00023 | |
| Domain | IQ_motif_EF-hand-BS | 8.93e-04 | 90 | 154 | 5 | IPR000048 | |
| Domain | LRRNT | 9.51e-04 | 53 | 154 | 4 | PF01462 | |
| Domain | RIH_assoc-dom | 9.91e-04 | 6 | 154 | 2 | IPR013662 | |
| Domain | - | 9.91e-04 | 6 | 154 | 2 | 3.90.1290.10 | |
| Domain | GAR | 9.91e-04 | 6 | 154 | 2 | PS51460 | |
| Domain | Ins145_P3_rec | 9.91e-04 | 6 | 154 | 2 | PF08709 | |
| Domain | GAS2 | 9.91e-04 | 6 | 154 | 2 | PF02187 | |
| Domain | RIH_assoc | 9.91e-04 | 6 | 154 | 2 | PF08454 | |
| Domain | RIH_dom | 9.91e-04 | 6 | 154 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 9.91e-04 | 6 | 154 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 9.91e-04 | 6 | 154 | 2 | IPR015925 | |
| Domain | - | 9.91e-04 | 6 | 154 | 2 | 1.25.10.30 | |
| Domain | - | 9.91e-04 | 6 | 154 | 2 | 3.30.920.20 | |
| Domain | RYDR_ITPR | 9.91e-04 | 6 | 154 | 2 | PF01365 | |
| Domain | GAS_dom | 9.91e-04 | 6 | 154 | 2 | IPR003108 | |
| Domain | GAS2 | 9.91e-04 | 6 | 154 | 2 | SM00243 | |
| Domain | - | 1.07e-03 | 248 | 154 | 8 | 1.25.40.20 | |
| Domain | ANK | 1.15e-03 | 251 | 154 | 8 | SM00248 | |
| Domain | ANK_REPEAT | 1.21e-03 | 253 | 154 | 8 | PS50088 | |
| Domain | ANK_REP_REGION | 1.24e-03 | 254 | 154 | 8 | PS50297 | |
| Domain | LRRNT | 1.31e-03 | 98 | 154 | 5 | IPR000372 | |
| Domain | LRRNT | 1.31e-03 | 98 | 154 | 5 | SM00013 | |
| Domain | Plectin | 1.38e-03 | 7 | 154 | 2 | PF00681 | |
| Domain | Cullin_CS | 1.38e-03 | 7 | 154 | 2 | IPR016157 | |
| Domain | CULLIN | 1.38e-03 | 7 | 154 | 2 | SM00182 | |
| Domain | Plectin_repeat | 1.38e-03 | 7 | 154 | 2 | IPR001101 | |
| Domain | - | 1.38e-03 | 7 | 154 | 2 | 3.40.50.1110 | |
| Domain | PLEC | 1.38e-03 | 7 | 154 | 2 | SM00250 | |
| Domain | P-loop_NTPase | TTF2 NLRP7 MYO1D ABCA13 MYO19 DHX38 LRRK2 DNAH2 TOR1A BTAF1 NLRC4 DHX15 MYH15 SLFN11 MYO15A MYO16 | 1.74e-03 | 848 | 154 | 16 | IPR027417 |
| Domain | SGNH_hydro | 1.83e-03 | 8 | 154 | 2 | IPR013830 | |
| Domain | Cullin_neddylation_domain | 1.83e-03 | 8 | 154 | 2 | IPR019559 | |
| Domain | Cullin_Nedd8 | 1.83e-03 | 8 | 154 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 1.83e-03 | 8 | 154 | 2 | SM00884 | |
| Domain | Ank_2 | 2.07e-03 | 215 | 154 | 7 | PF12796 | |
| Domain | Cullin_homology | 2.34e-03 | 9 | 154 | 2 | IPR016158 | |
| Domain | MIR | 2.91e-03 | 10 | 154 | 2 | PF02815 | |
| Domain | Leu-rich_rpt_4 | 2.91e-03 | 10 | 154 | 2 | IPR025875 | |
| Domain | MIR_motif | 2.91e-03 | 10 | 154 | 2 | IPR016093 | |
| Domain | Cullin | 2.91e-03 | 10 | 154 | 2 | PF00888 | |
| Domain | MIR | 2.91e-03 | 10 | 154 | 2 | PS50919 | |
| Domain | MIR | 2.91e-03 | 10 | 154 | 2 | SM00472 | |
| Domain | LRR_4 | 2.91e-03 | 10 | 154 | 2 | PF12799 | |
| Domain | CULLIN_2 | 2.91e-03 | 10 | 154 | 2 | PS50069 | |
| Domain | Cullin_N | 2.91e-03 | 10 | 154 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 2.91e-03 | 10 | 154 | 2 | PS01256 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.97e-03 | 35 | 154 | 3 | IPR002464 | |
| Domain | TPR-like_helical_dom | 3.24e-03 | 233 | 154 | 7 | IPR011990 | |
| Domain | DEAH_ATP_HELICASE | 3.75e-03 | 38 | 154 | 3 | PS00690 | |
| Domain | UBA | 5.68e-03 | 44 | 154 | 3 | IPR015940 | |
| Domain | CS | 5.76e-03 | 14 | 154 | 2 | PF04969 | |
| Domain | PI3/4_kinase_CS | 6.61e-03 | 15 | 154 | 2 | IPR018936 | |
| Domain | UBA | 6.84e-03 | 47 | 154 | 3 | PS50030 | |
| Domain | - | 7.47e-03 | 207 | 154 | 6 | 1.25.40.10 | |
| Domain | - | 7.51e-03 | 16 | 154 | 2 | 1.10.1070.11 | |
| Domain | CS | 7.51e-03 | 16 | 154 | 2 | PS51203 | |
| Domain | PI3Kc | 7.51e-03 | 16 | 154 | 2 | SM00146 | |
| Domain | CS_dom | 7.51e-03 | 16 | 154 | 2 | IPR007052 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.81e-09 | 5 | 171 | 4 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-11 | 2.25e-08 | 94 | 171 | 8 | 21542922 |
| Pubmed | UBR1 EMC1 NUP85 ORC3 MYO19 DHX38 APC EXOC3 BTAF1 EXOC8 SLC4A2 DST UPF2 NISCH ASB3 UGGT2 ULK1 | 2.65e-08 | 650 | 171 | 17 | 38777146 | |
| Pubmed | Centrosome-related genes, genetic variation, and risk of breast cancer. | 4.29e-08 | 102 | 171 | 8 | 20508983 | |
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 10516026 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TTF2 EMC1 NUP85 MYO1D MRS2 MYO19 MACROH2A1 USP19 ITPR3 MRPS30 THADA CDK5RAP3 DST UPF2 SNX6 RRS1 DNAAF10 RPUSD3 NISCH HINT2 TTC17 NEURL4 GOLGA3 PCNT | 3.58e-07 | 1496 | 171 | 24 | 32877691 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.65e-07 | 4 | 171 | 3 | 10469592 | |
| Pubmed | 4.65e-07 | 4 | 171 | 3 | 7983737 | ||
| Pubmed | CUL4B CUL4A NUP85 ORC3 NUMA1 EXOC3 TEX10 EXOC8 MRPS30 MED24 CDK5RAP3 CDC16 SLFN11 PCID2 | 8.07e-07 | 560 | 171 | 14 | 35241646 | |
| Pubmed | CUL4B MYO1D DHX38 NUMA1 USP24 FRYL TEX10 ITPR3 DHX15 DST RRS1 MACF1 ATM SPEN PCNT | 9.28e-07 | 653 | 171 | 15 | 22586326 | |
| Pubmed | 1.64e-06 | 18 | 171 | 4 | 18664271 | ||
| Pubmed | 2.31e-06 | 6 | 171 | 3 | 30442666 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NUP85 UBE4B HECTD4 IRF5 FRYL BTAF1 CNTROB ITGB5 ITPR3 CDR2L THADA DST LATS2 RRS1 NBEAL2 NISCH ULK1 SPEN PCNT | 2.43e-06 | 1105 | 171 | 19 | 35748872 |
| Pubmed | 2.57e-06 | 20 | 171 | 4 | 21689717 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EMC1 NUP85 MYO1D NUMA1 TOR1A EXOC3 MACROH2A1 BTAF1 TEX10 ITPR3 DHX15 DST RRS1 HINT2 MACF1 SPEN NEURL4 PCNT | 3.35e-06 | 1024 | 171 | 18 | 24711643 |
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 23142781 | ||
| Pubmed | TTF2 MRS2 UBE4B HECTD4 USP24 UBAP1 USP19 ITPR3 DST MACF1 NEURL4 PCNT | 5.17e-06 | 481 | 171 | 12 | 28190767 | |
| Pubmed | PLK2 UBE4B IFT172 HECTD4 APC RYR3 WDR19 DST SNX6 NISCH ASB3 GPSM2 MACF1 TTC17 ANKRD24 ANKRD36 ATM DNAI7 GOLGA3 PCNT | 5.76e-06 | 1285 | 171 | 20 | 35914814 | |
| Pubmed | UBE4B IFT172 ARHGEF12 USP19 ASAP1 RRS1 NISCH MACF1 ULK1 SPEN PCNT | 6.10e-06 | 407 | 171 | 11 | 12693553 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NUMA1 TOGARAM2 EXOC3 MACROH2A1 MEI1 TEX10 PARVG RYR3 RRS1 NBEAL2 ATM DNAI7 | 7.19e-06 | 497 | 171 | 12 | 36774506 |
| Pubmed | CAB39 UBE4B DHX38 GPS2 MAU2 ITGB5 USP19 PAPOLG NRARP PCED1B CENPP MED24 CDK5RAP3 UPF2 CDC16 RPUSD3 MYLIP SLFN11 GGPS1 PCNT | 9.22e-06 | 1327 | 171 | 20 | 32694731 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | NUP85 ORC3 DHX38 HECTD4 NUMA1 APC TEX10 ITPR3 RRS1 CDC16 NISCH | 1.26e-05 | 440 | 171 | 11 | 34244565 |
| Pubmed | Cell polarity and spindle orientation in the distal epithelium of embryonic lung. | 1.37e-05 | 10 | 171 | 3 | 21246661 | |
| Pubmed | EMC1 MRS2 TOR1A EXOC3 MACROH2A1 SLC4A2 ITPR3 WDR19 THADA CDK5RAP3 SNX6 RRS1 NISCH HINT2 MACF1 UGGT2 TTC17 ATM NEURL4 GOLGA3 PCNT | 1.44e-05 | 1487 | 171 | 21 | 33957083 | |
| Pubmed | MYO1D HUS1 ORC3 USP24 DNAH2 ITPR3 WDR19 ANKRD36B C17orf75 PRELP PI4KB SLFN11 SPEN | 1.80e-05 | 638 | 171 | 13 | 31182584 | |
| Pubmed | Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome. | 1.82e-05 | 32 | 171 | 4 | 20056645 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TTF2 EMC1 NUP85 UBE4B USP24 DNAH2 BTAF1 TEX10 USP19 EXOC8 SLC4A2 ITPR3 MED24 THADA NISCH UGGT2 | 1.83e-05 | 942 | 171 | 16 | 31073040 |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 26300260 | ||
| Pubmed | Distinct functions between toll-like receptors 3 and 9 in retinal pigment epithelial cells. | 2.40e-05 | 2 | 171 | 2 | 17534115 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 35967300 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 11002341 | ||
| Pubmed | Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3. | 2.40e-05 | 2 | 171 | 2 | 19535142 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 38520880 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 28093541 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 23665171 | ||
| Pubmed | Intramolecular interaction in LGN, an adaptor protein that regulates mitotic spindle orientation. | 2.40e-05 | 2 | 171 | 2 | 31732560 | |
| Pubmed | Immunological characterization of exocyst complex subunits in cell differentiation. | 2.40e-05 | 2 | 171 | 2 | 12954101 | |
| Pubmed | Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer. | 2.40e-05 | 2 | 171 | 2 | 27974468 | |
| Pubmed | Voltage-Gated Proton Channel Hv1 Controls TLR9 Activation in Plasmacytoid Dendritic Cells. | 2.40e-05 | 2 | 171 | 2 | 33127821 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 25388852 | ||
| Pubmed | Costimulatory activation of murine invariant natural killer T cells by toll-like receptor agonists. | 2.40e-05 | 2 | 171 | 2 | 22795895 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 15703190 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 21132533 | ||
| Pubmed | CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis. | 2.40e-05 | 2 | 171 | 2 | 19481525 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 29860675 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 21816348 | ||
| Pubmed | Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. | 2.40e-05 | 2 | 171 | 2 | 21398612 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 12077329 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 12393421 | ||
| Pubmed | The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice. | 2.40e-05 | 2 | 171 | 2 | 19120284 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 16847112 | ||
| Pubmed | [TLR3c.1377, TLR9-1486, and TLR9 2848 gene polymorphisms and multiple sclerosis]. | 2.40e-05 | 2 | 171 | 2 | 20197609 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 31101817 | ||
| Pubmed | Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosis. | 2.40e-05 | 2 | 171 | 2 | 18339895 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 32631940 | ||
| Pubmed | Expression of Toll‑like receptors 3 and 9 in Egyptian systemic lupus erythematosus patients. | 2.40e-05 | 2 | 171 | 2 | 26680366 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 16751377 | ||
| Pubmed | Cul4A is required for hematopoietic stem-cell engraftment and self-renewal. | 2.40e-05 | 2 | 171 | 2 | 17616641 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 9060628 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20064923 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 2.40e-05 | 2 | 171 | 2 | 9460924 | |
| Pubmed | The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma. | 2.40e-05 | 2 | 171 | 2 | 23467704 | |
| Pubmed | Harmful Roles of TLR3 and TLR9 in Cardiac Dysfunction Developing during Polymicrobial Sepsis. | 2.40e-05 | 2 | 171 | 2 | 30364002 | |
| Pubmed | Regulation of osteoclastogenesis by integrated signals from toll-like receptors. | 2.40e-05 | 2 | 171 | 2 | 25079212 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 11852051 | ||
| Pubmed | The transmembrane domain directs TLR9 to intracellular compartments that contain TLR3. | 2.40e-05 | 2 | 171 | 2 | 16554027 | |
| Pubmed | ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression. | 2.40e-05 | 2 | 171 | 2 | 27023913 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 26911613 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 17700532 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 32939755 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 12445386 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 38761506 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20137629 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 38652550 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 37532523 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 22575700 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 2.40e-05 | 2 | 171 | 2 | 11672541 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 12408049 | ||
| Pubmed | A mammalian Partner of inscuteable binds NuMA and regulates mitotic spindle organization. | 2.40e-05 | 2 | 171 | 2 | 11781568 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 34906906 | ||
| Pubmed | 2.49e-05 | 12 | 171 | 3 | 14557543 | ||
| Pubmed | 2.69e-05 | 313 | 171 | 9 | 20800603 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 2.97e-05 | 120 | 171 | 6 | 31413325 | |
| Pubmed | NUP85 NLRP7 MYO1D NUMA1 DNAH2 RDH12 MACROH2A1 TEX10 DST LATS2 RRS1 MACF1 MYH15 UGGT2 ATM ULK1 SPEN TBX1 PCID2 PCNT | 3.02e-05 | 1442 | 171 | 20 | 35575683 | |
| Pubmed | 4.09e-05 | 14 | 171 | 3 | 30779731 | ||
| Pubmed | CRL4-DCAF8L2 E3 ligase promotes ubiquitination and degradation of BARD1. | 5.09e-05 | 15 | 171 | 3 | 35487060 | |
| Pubmed | 5.13e-05 | 81 | 171 | 5 | 20301590 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 5.22e-05 | 341 | 171 | 9 | 32971831 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 27505671 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 16467204 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 24692849 | ||
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 7.19e-05 | 3 | 171 | 2 | 12399109 | |
| Pubmed | Dynamic control of nucleic-acid-sensing Toll-like receptors by the endosomal compartment. | 7.19e-05 | 3 | 171 | 2 | 34223897 | |
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 30321082 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 25121361 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 9971820 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 32587774 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 20804821 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 28544067 | ||
| Pubmed | 7.19e-05 | 3 | 171 | 2 | 15634897 | ||
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.13e-05 | 181 | 106 | 8 | 694 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD36C ASAP1 NRARP ANKRD36B RFXANK ASB3 ANKRD24 ANKRD36 MYO16 | 1.26e-05 | 242 | 106 | 9 | 403 |
| GeneFamily | EF-hand domain containing|Plakins | 9.32e-04 | 8 | 106 | 2 | 939 | |
| GeneFamily | Cullins | 9.32e-04 | 8 | 106 | 2 | 1032 | |
| GeneFamily | Exocyst complex | 1.19e-03 | 9 | 106 | 2 | 1055 | |
| GeneFamily | CD molecules|Toll like receptors | 1.49e-03 | 10 | 106 | 2 | 948 | |
| GeneFamily | Small leucine rich repeat proteoglycans | 2.16e-03 | 12 | 106 | 2 | 573 | |
| GeneFamily | DEAH-box helicases | 3.87e-03 | 16 | 106 | 2 | 500 | |
| GeneFamily | Sulfatases | 4.90e-03 | 18 | 106 | 2 | 410 | |
| GeneFamily | T-boxes | 4.90e-03 | 18 | 106 | 2 | 766 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | PCED1A TTF2 GPS2 TOGARAM2 RUSC1 MAU2 PI4KAP2 PARVG ITPR3 PCED1B ANKRD36B CDK5RAP3 FCN1 NISCH QPCT ANKRD36 ULK1 SPEN PCNT | 3.84e-06 | 905 | 163 | 19 | M40865 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 7.63e-06 | 212 | 163 | 9 | M39221 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-08 | 184 | 163 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-08 | 184 | 163 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-08 | 184 | 163 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-07 | 175 | 163 | 8 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.18e-07 | 190 | 163 | 8 | e5625feb21915d4545cfad2659745ef180efcb1f | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.78e-06 | 156 | 163 | 7 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-06 | 175 | 163 | 7 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.70e-06 | 186 | 163 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-06 | 188 | 163 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-06 | 188 | 163 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-06 | 188 | 163 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.78e-06 | 191 | 163 | 7 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 7.26e-06 | 193 | 163 | 7 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.26e-06 | 193 | 163 | 7 | c9e3fefa8d68d0e2b954f85ce37813185ff98d84 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.26e-06 | 193 | 163 | 7 | 888b11d7d66970931d1c33bea714659ca3cfe149 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.26e-06 | 193 | 163 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.26e-06 | 193 | 163 | 7 | 9a6c5b7c8e88cf7a261f8e052df1709d2c0a91f0 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.76e-06 | 195 | 163 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.76e-06 | 195 | 163 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.30e-06 | 197 | 163 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Non-cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.30e-06 | 197 | 163 | 7 | b843e9d664f909c1c12d72b93bd2b3279ca12a59 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.86e-06 | 199 | 163 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.86e-06 | 199 | 163 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.15e-06 | 200 | 163 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 9.15e-06 | 200 | 163 | 7 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.15e-06 | 200 | 163 | 7 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.15e-06 | 200 | 163 | 7 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-cDC2|ICU-NoSEP / Disease, condition lineage and cell class | 9.15e-06 | 200 | 163 | 7 | 59cb0b0dee2599b3d3014b66d71d84c22b5de4b2 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.15e-06 | 200 | 163 | 7 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.15e-06 | 200 | 163 | 7 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 9.15e-06 | 200 | 163 | 7 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 9.15e-06 | 200 | 163 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-05 | 153 | 163 | 6 | 6a2a2379238133ce0ad714af130ffe02dd317247 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-05 | 153 | 163 | 6 | faa442dd925b2b09919e93c492ccc3f19803ad24 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.48e-05 | 157 | 163 | 6 | 29622bac6b16bb39cec4319bf4c4f92d33345e8a | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-05 | 159 | 163 | 6 | a5fee9e7ee00c20a4ba30b0dfaf1189fb109a1af | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.39e-05 | 166 | 163 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-05 | 169 | 163 | 6 | 3e40ae0b23a962e0f15908872dec63f51c5b8b83 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 169 | 163 | 6 | 149a4f83da15bdeb170e980fb5b5b1af89ae07a6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.13e-05 | 172 | 163 | 6 | cf46810dd1072b6f2171e5d9530351ddc79a055b | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 174 | 163 | 6 | 28ec25767bbd4fd898738f9f4d2b585dc91b5adf | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.55e-05 | 175 | 163 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.55e-05 | 175 | 163 | 6 | 3031f1eef3cfef8a7e5f57e567cb0868d06cac38 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 175 | 163 | 6 | 0801cccec6915aefc135262fc74580280fd51aa5 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 175 | 163 | 6 | 09163e7030f76d706eccabdb1d5ec45f8412aa75 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 177 | 163 | 6 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-05 | 177 | 163 | 6 | 68f1139fc378f351e3b9e9f392aacb150025bf03 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 178 | 163 | 6 | 8c5e9fab7b55a654ccaabf2c4d02397399d94616 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 179 | 163 | 6 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.49e-05 | 181 | 163 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.66e-05 | 182 | 163 | 6 | 93841f730ca1a735eaaf5f2ccbe5c45ab0e029d1 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-1|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.84e-05 | 183 | 163 | 6 | cd00e2cd901df4b3f5f7aed747cc0b47f6d3c811 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 6.02e-05 | 184 | 163 | 6 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 6.20e-05 | 185 | 163 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-05 | 185 | 163 | 6 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-05 | 185 | 163 | 6 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-05 | 185 | 163 | 6 | ed7b26bdebfd0df2b4f5020a855a052d94ae7219 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.39e-05 | 186 | 163 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 6.39e-05 | 186 | 163 | 6 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.77e-05 | 188 | 163 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.77e-05 | 188 | 163 | 6 | 8fc15c8b78fdd1a578e34325011bc5a87a8aab31 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.77e-05 | 188 | 163 | 6 | adf9011ba8e3c6418fb68bf5c44b2e3b0ec7dafe | |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | 6.98e-05 | 189 | 163 | 6 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.98e-05 | 189 | 163 | 6 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.98e-05 | 189 | 163 | 6 | a438c64a893d43f781ede42e1c7b615b74dc76ef | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.18e-05 | 190 | 163 | 6 | b7ce76931edc6734b80ddbb2fca23b098a8c1352 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.18e-05 | 190 | 163 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.18e-05 | 190 | 163 | 6 | 6a70d92cf66bdc9dade218b530f040f1581926f1 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.39e-05 | 191 | 163 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.39e-05 | 191 | 163 | 6 | bce138f067b8962ecef1ddec6511a3f142d81d78 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 191 | 163 | 6 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.61e-05 | 192 | 163 | 6 | d44f46352bac414b45cc749f7cbdc3a159bd7ae8 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.61e-05 | 192 | 163 | 6 | 0ba5729a890bfba5db567cd0eec7924cd1991ac3 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.61e-05 | 192 | 163 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.61e-05 | 192 | 163 | 6 | 8b4bbbadeac70f65378697120c754f10501b5651 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.61e-05 | 192 | 163 | 6 | 4e3deefd30adb7bf1eba294610eed3d077aa9418 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-05 | 193 | 163 | 6 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.83e-05 | 193 | 163 | 6 | e1855cff9a6bcfda9188b9fdf6c9d698405da990 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-05 | 193 | 163 | 6 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-05 | 193 | 163 | 6 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.83e-05 | 193 | 163 | 6 | 2684fa361baaa9dc7a18a39ed11c0759e78e4418 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-05 | 193 | 163 | 6 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.06e-05 | 194 | 163 | 6 | 6b48383151b678489bcd6133d389a5d8b3a50186 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.06e-05 | 194 | 163 | 6 | fad22d5cf62016cad979e6943e357106d8d2a4b4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.06e-05 | 194 | 163 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.06e-05 | 194 | 163 | 6 | b4401777b03773ddc04bf13236c9528027f928b7 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.06e-05 | 194 | 163 | 6 | 260649f5c4aeaa9cbf5ed5ae5e9f293d75bb0457 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-05 | 195 | 163 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.29e-05 | 195 | 163 | 6 | 518cc3baeb7cf2ad068692cbe85fd75be67f1872 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 8.52e-05 | 196 | 163 | 6 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class | 8.52e-05 | 196 | 163 | 6 | f73573b5d9c735f2a2c718472b7d12b10f2a3718 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.52e-05 | 196 | 163 | 6 | b2aee2f67da373a10b0c25e7797e30e3811543a8 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.52e-05 | 196 | 163 | 6 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.52e-05 | 196 | 163 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 8.64e-05 | 122 | 163 | 5 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-05 | 197 | 163 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.76e-05 | 197 | 163 | 6 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.76e-05 | 197 | 163 | 6 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.76e-05 | 197 | 163 | 6 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.01e-05 | 198 | 163 | 6 | 2dc0510846cbc296a300b8465e7be9b39f479852 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.50e-05 | 50 | 95 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; HL60; HG-U133A | 1.79e-06 | 199 | 163 | 10 | 1729_UP | |
| Disease | cancer (implicated_via_orthology) | 1.95e-05 | 268 | 163 | 9 | DOID:162 (implicated_via_orthology) | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 5.76e-05 | 14 | 163 | 3 | DOID:0060413 (implicated_via_orthology) | |
| Disease | glycerate measurement | 7.17e-05 | 15 | 163 | 3 | EFO_0021029 | |
| Disease | gestational trophoblastic neoplasm (is_implicated_in) | 1.81e-04 | 4 | 163 | 2 | DOID:3590 (is_implicated_in) | |
| Disease | Complete hydatidiform mole | 1.81e-04 | 4 | 163 | 2 | C0678213 | |
| Disease | airway responsiveness measurement | 3.08e-04 | 24 | 163 | 3 | EFO_0006897 | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 4.90e-04 | 28 | 163 | 3 | DOID:7998 (biomarker_via_orthology) | |
| Disease | anorexia nervosa | 6.20e-04 | 70 | 163 | 4 | MONDO_0005351 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 7.99e-04 | 33 | 163 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | hepatitis C (is_marker_for) | 9.51e-04 | 35 | 163 | 3 | DOID:1883 (is_marker_for) | |
| Disease | cerebrospinal fluid clusterin measurement | 9.51e-04 | 35 | 163 | 3 | EFO_0007657 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.03e-03 | 206 | 163 | 6 | C0152013 | |
| Disease | hepatitis B (is_implicated_in) | 1.12e-03 | 37 | 163 | 3 | DOID:2043 (is_implicated_in) | |
| Disease | Human papillomavirus infectious disease (is_marker_for) | 1.33e-03 | 10 | 163 | 2 | DOID:11166 (is_marker_for) | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.33e-03 | 10 | 163 | 2 | GO_0097327, GO_0097328 | |
| Disease | level of Ceramide (d42:1) in blood serum | 1.33e-03 | 10 | 163 | 2 | OBA_2045187 | |
| Disease | Jeune thoracic dystrophy | 1.61e-03 | 11 | 163 | 2 | C0265275 | |
| Disease | testosterone measurement | UBR1 CYP7A1 DNAH2 UBAP1 C16orf96 MAU2 NLRC4 SHROOM4 THADA HMCN1 NISCH ASB3 MACF1 MYO15A MYO16 WDR72 | 1.93e-03 | 1275 | 163 | 16 | EFO_0004908 |
| Disease | Leber congenital amaurosis (implicated_via_orthology) | 2.27e-03 | 13 | 163 | 2 | DOID:14791 (implicated_via_orthology) | |
| Disease | Retinitis Pigmentosa | 2.69e-03 | 104 | 163 | 4 | C0035334 | |
| Disease | anemia (implicated_via_orthology) | 3.04e-03 | 15 | 163 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Leber congenital amaurosis | 3.46e-03 | 16 | 163 | 2 | cv:C0339527 | |
| Disease | response to triptolide, cytotoxicity measurement | 3.46e-03 | 16 | 163 | 2 | EFO_0006952, EFO_0007662 | |
| Disease | dual specificity mitogen-activated protein kinase kinase 2 measurement | 3.46e-03 | 16 | 163 | 2 | EFO_0008112 | |
| Disease | Benign neoplasm of stomach | 3.91e-03 | 17 | 163 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.91e-03 | 17 | 163 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 3.91e-03 | 17 | 163 | 2 | C0154060 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 3.91e-03 | 17 | 163 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | apolipoprotein B measurement | CYP7A1 DHX38 GPS2 USP24 AKNAD1 THADA NISCH MYLIP GPSM2 CMAHP | 3.92e-03 | 663 | 163 | 10 | EFO_0004615 |
| Disease | non-alcoholic steatohepatitis (is_marker_for) | 4.38e-03 | 18 | 163 | 2 | DOID:0080547 (is_marker_for) | |
| Disease | protein Z-dependent protease inhibitor measurement | 4.38e-03 | 18 | 163 | 2 | EFO_0021849 | |
| Disease | leukemia (implicated_via_orthology) | 4.88e-03 | 19 | 163 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis, COVID-19 | 5.39e-03 | 64 | 163 | 3 | EFO_0000685, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLLFDDALVLLQGHN | 251 | Q60I27 | |
| GEIILALHQLDLLQK | 291 | Q6UWY0 | |
| GHLLNFTLVQDLKLS | 91 | Q9NYP8 | |
| VARVLGALLHFLKEQ | 211 | P16452 | |
| LQKGSGFHLDLLLIV | 1026 | P04920 | |
| FLTQAVILGLQEKHL | 2436 | Q96N23 | |
| QDLHLAAELGKTLLE | 26 | Q86X02 | |
| LHDFELNKLKENLGI | 876 | Q75V66 | |
| EEAHLLLKAFQIKGQ | 3406 | Q96PZ7 | |
| EMIKNGAFLDLLQHL | 851 | Q7Z2Y8 | |
| LFLGQKLNLIHSEIS | 191 | O75367 | |
| LLALQEEKHQLFLQL | 76 | Q13227 | |
| DLFKLNQDLGSALHL | 2401 | Q86UQ4 | |
| FDRHLLGLKLQAIED | 516 | P43155 | |
| KLLGELLLDRHNFTI | 231 | Q9Y376 | |
| DDVKILANGLLQLGH | 41 | Q9Y5C1 | |
| TLGEKDIVILLLQHN | 206 | A6QL64 | |
| GEKDIVILLLQHNID | 196 | Q8N2N9 | |
| LAGDKLILHLLQEAA | 256 | Q8TF21 | |
| VLQLKKLGIDDLVHF | 511 | O43143 | |
| LKNQLGHLESELSFL | 56 | Q6IPU0 | |
| GIDLHEFLINTLKNN | 146 | Q9UBL0 | |
| IFSNLEDILQLHIGL | 831 | Q9NZN5 | |
| QELKHLILEAADGFL | 136 | Q9HBZ2 | |
| LLIGQLEGFFLHLKE | 246 | Q9HBI0 | |
| LQAIEHELHELGLLK | 271 | Q16769 | |
| NEKIFQESIGLAIHL | 1746 | Q14573 | |
| LLGNIHAVTKQLLEE | 321 | Q9UJ83 | |
| INIVLKDHQFLEGKL | 311 | Q96RS6 | |
| LLIVSFNHDVLGKNL | 16 | Q9HCL0 | |
| GQHLFEITNLEKLEN | 896 | Q6ZRR7 | |
| TLGEKDIVILLLQHN | 206 | Q5JPF3 | |
| GFLAEEKQLHILINN | 111 | Q96NR8 | |
| LKHLQVLDIEGNLEF | 571 | Q7Z5L7 | |
| ILLGFFKQDEHQNLL | 26 | Q8NH92 | |
| QLLHLELSENKLLIF | 511 | A4D1F6 | |
| KENLIGALLAIFGHL | 31 | Q6P499 | |
| IFGHLVVSIALNLQK | 41 | Q6P499 | |
| LKHLAIAQELNDRIG | 306 | P81274 | |
| EDQQLLGHLLLVAKQ | 106 | Q9BX68 | |
| LRIFHNLKDVGFLQV | 616 | Q6DN14 | |
| AQNLHNLVKLSILDL | 841 | Q9NPP4 | |
| HQSVIDGNLELVKLL | 56 | Q7Z6K4 | |
| NILIDLDGHIKLTDF | 796 | Q9NRM7 | |
| VIFKNLHHLELLGLT | 136 | A6NIV6 | |
| LALQQAFIHKQAVLL | 2451 | Q9UKN7 | |
| NLFVILAAILHLGDI | 661 | Q9Y6X6 | |
| IFKVLAGLLHLGNIQ | 296 | Q96H55 | |
| LLALGQFQHALDELL | 6376 | Q03001 | |
| IVLLFQEHQFEALGL | 186 | Q96D96 | |
| FLQDNELRHLILKTA | 176 | Q8WYA1 | |
| IQLYEIQHGDLKLLR | 46 | Q96MX6 | |
| QILRKLFNESHGIFL | 66 | Q9BW27 | |
| VQQLLHNKFVVILGD | 26 | Q9H1Q7 | |
| QLLHNKFVVILGDSV | 11 | Q96HM7 | |
| LLETLKFGVLELQEH | 2771 | O94915 | |
| LHILLQNGKSLSELE | 231 | Q9HD23 | |
| LEALHLLANEQLEKG | 46 | P63132 | |
| DLKGHLASLFLNENI | 291 | Q8WY64 | |
| DIHKLVLAALNRFIG | 541 | Q5S007 | |
| AVKLFTRQLLELHQG | 111 | O95749 | |
| NEIFKDLHQLRVLNL | 81 | Q96PB8 | |
| SLEHFLNELILFQKG | 371 | Q13568 | |
| AEALFLLEKGQHQTI | 671 | A2A3K4 | |
| EEQLLHFLGQLLGIA | 3696 | Q9Y4D8 | |
| FIIHALLVKDIQGAL | 541 | Q8IYI6 | |
| QAGLLEHLKLENVSL | 606 | Q08378 | |
| LLGEKLAENNINLIF | 321 | P18084 | |
| LLFQEKLTFLLHAAL | 211 | Q9HAS0 | |
| LGLETEHKVQLSLLQ | 671 | O95613 | |
| LEALHLLANEQLEKG | 46 | P63135 | |
| LEALHLLANEQLEKG | 46 | Q9BXR3 | |
| ALLALGQFQHALEEL | 6221 | Q9UPN3 | |
| VELLDRGQVLHLKNA | 1501 | Q96RW7 | |
| LLNKLGLLEAAVDHA | 1106 | Q9UG01 | |
| NNIELHKQGLLLFAE | 381 | Q5TIA1 | |
| HKQGLLLFAEILTRQ | 386 | Q5TIA1 | |
| AIQVLRFHLLELEKG | 136 | A8K0S8 | |
| DFIQELLAKLQGLHR | 106 | Q96A00 | |
| LEALHLLANEQLEKG | 46 | Q9QC07 | |
| GLAVLLVLFLHIKNL | 11 | O00602 | |
| VSEGNLLLLHEALAK | 286 | Q5JVF3 | |
| ELNHRLVVLGKLNNL | 56 | Q9BWT3 | |
| HLDLLTGNLLLNEKL | 76 | Q9Y5E9 | |
| GKILELLQDLHVADN | 266 | P34059 | |
| NLLGKQIDHLFISNL | 1326 | Q13315 | |
| HIGTLVELNKANELF | 271 | Q13042 | |
| ILLKYGAQINELHLA | 336 | Q9Y575 | |
| FLHLVLDKLFQLSVQ | 791 | Q8NF50 | |
| RHFLEQLLDGKKLEN | 1241 | O14981 | |
| LNFKALHLLLHGILE | 21 | A6NNT2 | |
| AILQKGLDHLLDENR | 301 | Q13619 | |
| EDLIGKLTSLQLQHL | 406 | Q96JB5 | |
| ALQGKEQHLLEQAEL | 1976 | Q9BV73 | |
| QESILQLQELLHLKF | 166 | Q6TDU7 | |
| QLQELLHLKFGVATE | 171 | Q6TDU7 | |
| VLEKLQGHLELLEQN | 416 | Q5T1N1 | |
| QGHLELLEQNFLATK | 421 | Q5T1N1 | |
| LLKNLLQGLSHNVIF | 131 | Q9ULH1 | |
| LHLLDQVFFQELLKT | 121 | Q7Z6J4 | |
| GRLFAIHEIKQFLIL | 446 | P22680 | |
| EDHLLLFLQQLAGKV | 426 | Q8N766 | |
| IGDQILDLSIIKHLF | 36 | P16930 | |
| FVLNDGNVHLISLKI | 786 | P82279 | |
| DLIEQGALLQAHRKL | 131 | O60645 | |
| LGVSLQLVDALKHDL | 1071 | Q9P225 | |
| RLLFQLAQLHTLEKD | 146 | Q9Y6X3 | |
| EHLTAILQKGLNNLL | 451 | Q13620 | |
| TLEFLENHGKNILLS | 1131 | Q96JN8 | |
| LEGLKNFLHQLLETV | 706 | Q8N137 | |
| LEKNVNQSLLELHAL | 166 | Q8N4E7 | |
| LKFVLDHEDGLNLNE | 131 | Q14980 | |
| QLAAQGELDQLKEHL | 96 | O14593 | |
| GSHLKLIVDAFLQQL | 561 | Q9HAU5 | |
| VQNFIKGLQLSLLEH | 321 | Q9UBD5 | |
| FHAFILGLLNTKQLE | 596 | Q9BVN2 | |
| KGFNDDVLLQIVHFL | 411 | Q9NP92 | |
| IQAALKLEHIDGVNL | 186 | Q6P087 | |
| NVLHFLQKSLIEILE | 161 | Q6YHU6 | |
| INLLQEQGAEKVLLH | 156 | Q17R31 | |
| FSIVLLLNGIIKDHF | 101 | A0A494BZU4 | |
| HLSAVLEQIGAEKLL | 631 | Q6ZUX3 | |
| LLQDGVTLHDVKALQ | 356 | P48378 | |
| QILSGQKELHDLLLV | 301 | Q9Y2K3 | |
| ENVSKHLGLSQLELI | 111 | Q9Y2N7 | |
| HQADLEQALLLLKLF | 71 | Q6ZNJ1 | |
| HIDIRKLLQFLAGQQ | 231 | O60921 | |
| VKHLGLQEFIILNLV | 161 | Q6NW34 | |
| AIEHSLLKLGEILAN | 191 | O75448 | |
| HLFVGDLDKVVNLLL | 1366 | Q9ULL8 | |
| GLEHKKELQQLLFSV | 386 | Q7Z7L1 | |
| LKHLRLSANVLLDEG | 791 | Q8WX94 | |
| FSKLENLLLLDLQHN | 191 | P51888 | |
| KDELLTNQLIDHLLG | 1066 | Q8NEZ3 | |
| LLQVKDRHNGNILLD | 666 | Q9UBF8 | |
| LLFLLQIKDRHNGNI | 436 | A4QPH2 | |
| LIQLLHGNDKDSVLL | 356 | P25054 | |
| LEILNAALGDEIFLH | 336 | Q9Y471 | |
| QEVLKLTLGHEQFRL | 376 | Q6ZU45 | |
| IKNQLGLTLEAHLSE | 121 | Q8N9Z0 | |
| LEALHLLANEQLEKG | 46 | P63136 | |
| FLIAGKLQDGLLHIT | 106 | P01033 | |
| LLALEFLQEKHLFHG | 236 | Q6J9G0 | |
| LKLTNNLLDDNGHII | 171 | O75333 | |
| LLDGLHEDLNRIQNK | 596 | O94966 | |
| LEGLEKLEILDLQHN | 526 | O15455 | |
| GFELKDIKEVLLLHN | 471 | Q9NZ09 | |
| DDNLFGQHLAKKIIL | 66 | O14656 | |
| GLLALKNDTAAVQLH | 3511 | Q96T58 | |
| GRLEKHLELFLQQLQ | 616 | Q9UJ98 | |
| NAFGKLHLLQVLILN | 171 | O94991 | |
| TGLQVLDLSHNKLDL | 521 | Q9NR96 | |
| KDQTFLLHLLEVGFL | 2376 | Q15413 | |
| VHKELELQFDLGNLL | 26 | Q15050 | |
| GRQELFKILHSILLN | 636 | O95155 | |
| LELQIGNALFIGKHL | 126 | P05543 | |
| KIEFLDLSHNGLLVV | 311 | Q9Y2I1 | |
| LEALHLLANEQLEKG | 46 | P10266 | |
| LEALHLLANEQLEKG | 46 | P63133 | |
| NVGFHILLFDLENLV | 676 | Q3MJ13 | |
| HILALGLLEEKQQLQ | 916 | Q8IWV7 | |
| ELHIFQIKGEIANQL | 166 | Q8N4W9 | |
| LEALHLLANEQLEKG | 46 | Q9UQG0 | |
| INELLHILVFGESLL | 251 | P19634 | |
| FVELISHQQLSKGLI | 186 | Q9NXF1 | |
| LLLKSLGVQDLLQFH | 896 | Q92620 | |
| HLDATKLLLQALAIN | 671 | Q96AE7 | |
| AELELKHAKGNLQLL | 381 | Q9UNH7 | |
| QKLLHQLGFSDEQIL | 1016 | Q9UPU5 | |
| LEALHLLANEQLEKG | 46 | Q9WJR5 | |
| ILHRDLKLGNFFINE | 201 | Q9NYY3 | |
| LKLTNNLLDDNGHII | 216 | O43435 | |
| LFLENGLNLRKFLTH | 476 | Q7Z2W7 | |
| LKKAGQFLDNLHINL | 91 | Q9NYU1 | |
| LLFVQHVLEIAALKG | 851 | O75385 | |
| LLHEDFVVELQGLLL | 51 | Q9UNY4 | |
| HTLAFKLQLAVLQGL | 976 | O43156 | |
| LAAILHLGNLKFVVD | 271 | O94832 | |
| LLVLAVLFFHQLVGD | 96 | Q53FP2 |